Takeshi Onoue

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Left Atrial Appendage

Catheter Ablation

Direct Oral Anticoagulants

Acute Heart Failure

Top Venues

Circulation. Cardiovascular imaging

Clinical drug investigation

This page only lists publications with an associated author ORCID identifier.

Publications

Jun Akashi, Mai Iwataki, Yosuke Nabeshima, Takeshi Onoue, Atsushi Hayashi, Tetsuo Tanaga, Shun Nishino, Toshiyuki Kimura, Mitsuhiro Yano, Nozomi Watanabe, Yuki Tsuda, Masaru Araki, Yoshisato Shibata, Yosuke Nishimura, Yutaka Otsuji, Masaharu Kataoka
Potential Effects of Mild Atrial Secondary Mitral Regurgitation in Patients With Isolated Atrial Fibrillation. Circulation. Cardiovascular imaging 17 (3) (2024)
Jun Akashi, Mai Iwataki, Yosuke Nabeshima, Takeshi Onoue, Atsushi Hayashi, Tetsuo Tanaga, Shun Nishino, Toshiyuki Kimura, Mitsuhiro Yano, Nozomi Watanabe, Yuki Tsuda, Masaru Araki, Yoshisato Shibata, Yosuke Nishimura, Yutaka Otsuji, Masaharu Kataoka
Potential Effects of Mild Atrial Secondary Mitral Regurgitation in Patients With Isolated Atrial Fibrillation. Circulation. Cardiovascular imaging 17 (3) (2024)
Jun Akashi, Mai Iwataki, Yosuke Nabeshima, Takeshi Onoue, Atsushi Hayashi, Tetsuo Tanaga, Shun Nishino, Toshiyuki Kimura, Mitsuhiro Yano, Nozomi Watanabe, Yuki Tsuda, Masaru Araki, Yoshisato Shibata, Yosuke Nishimura, Yutaka Otsuji, Masaharu Kataoka
Potential Effects of Mild Atrial Secondary Mitral Regurgitation in Patients With Isolated Atrial Fibrillation. Circulation. Cardiovascular imaging 17 (3) (2024)
Jun Akashi, Mai Iwataki, Yosuke Nabeshima, Takeshi Onoue, Atsushi Hayashi, Tetsuo Tanaga, Shun Nishino, Toshiyuki Kimura, Mitsuhiro Yano, Nozomi Watanabe, Yuki Tsuda, Masaru Araki, Yoshisato Shibata, Yosuke Nishimura, Yutaka Otsuji, Masaharu Kataoka
Potential Effects of Mild Atrial Secondary Mitral Regurgitation in Patients With Isolated Atrial Fibrillation. Circulation. Cardiovascular imaging (2024)
Takeshi Onoue, Masaharu Kataoka
SGLT2 Inhibitors Improve Cardiac Failure by Reducing Whole-Body Oxygen Demand: A Hypothesis. Clinical drug investigation 42 (12) (2022)